MRI for hepatocellular carcinoma: a primer for magnetic resonance imaging interpretation
Hepatocellular carcinoma is among the most prevalent solid organ cancers, and, unlike many cancers, may be diagnosed non-invasively by imaging criteria  with the preferred modality recently shifting from multiphasic computed tomography (MDCT) to magnetic resonance imaging (MRI). The purpose of this article is to help facilitate radiologists and radiology trainees in the transition to MRI by providing a step-wise approach to exam interpretation to improve the MRI detection of HCC. A methodical, consistent approach to navigating a HCC screening MRI exam, in conjunction with the LI-RADS framework for characterization, should lead to improved HCC detection and diagnosis.
KeywordsMagnetic resonance imaging MRI protocol Liver imaging Hepatocellular carcinoma
Compliance with ethical standards
Conflicts of interest
None of the authors have any potential conflicts of interest to disclose.
IRB approval was not required and for this type of study informed consent is not required.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Llovet JM, Ducreux M, Lencioni R, et al. (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European Association for Study of Liver; European Organisation for Research and Treatment of Cancer. Eur J Cancer 48(5):599–641. doi: 10.1016/j.ejca.2011.12.021 CrossRefGoogle Scholar
- 8.LI-RADS v2014: www.acr.org/Quality-Safety/Resources/LIRADS